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Case Report
Anaesthetic challenges in emergency surgical repair of acute aortic
dissection rupturing into the pericardium in a pregnant patient
Mohammad Irfan Akhtar, Khalid Samad
Department of Anaesthesia, Aga Khan University Hospital, Karachi.
Abstract
Acute aortic dissection in pregnancy is a serious
situation, because rapid and appropriate surgical decision
making is required to save the life of both mother and baby.
Aortic dissection is rare in young women but is likely during
pregnancy (third trimester) secondary to the hyperdynamic and
hypervolaemic circulatory state associated with pregnancy. A
35 years old 27 weeks pregnant patient weighing 90 kg
presented in the emergency with severe chest pain. In the
immediate post cardiopulmonary bypass period, the patient
started bleeding profusely from the anastamotic sites
irrespective of utilization of all the conventional methods of
haemostasis including multiple units of whole blood, fresh
frozen plasma, platelets, calcium and cryoprecipitates. As a last
resort she was given low dose r FVIIa (1.2 mg containing 60
KIU of Factor VII). This stopped the bleeding and the
haemodyramics were stabilized.
Keywords: Aortic dissection, pregnant patient, recombinant
activated factor VII (r FVII a).
Introduction
Aortic dissection is an often fatal disorder in which
the inner layer of the aortic wall gets torn. Aortic dissection
can be categorized on the basis of DeBakey ( I,II and III ) or
Stanford classification ( class A (I and II) and B(III).1
Transesophageal Echocardiography (TEE) is a
relatively good test for the diagnosis of aortic dissection, with
a sensitivity of up to 98% and a specificity of up to 97%.2
Aortic dissection is rare in young women and is more
during the pregnancy (third trimester) secondary to the
hyperdynamic and hypervolaemic circulatory state associated
with pregnancy.3
Acute aortic dissection in pregnancy requires rapid
and appropriate surgical decision making to save the life of
both mother and baby. Aortic root enlargement (> 4 cm) and
Marfan syndrome significantly predispose to aortic dissection
in pregnancy.4
Recombinant FVIIa is a genetically engineered
product that was first introduced in 1988 for the treatment of
patients with haemophilia A and B with high inhibitory
antibody titres to factors VIII and IX. The mode of action of
activated recombinant factor VII is not completely clear. It is
thought to form a complex by binding tissue factor at the site
of vascular damage and this activates the intracellular
mechanism of coagulation within the platelets. 
We are reporting a case of a pregnant woman who
presented with acute aortic dissection that was found to have
extended in retrograde direction causing haemopericardium
and aortic valve incompetence, which is rare.
Case Report
A 35 years old, 27 weeks pregnant woman weighing
90 kg, presented in the emergency with severe chest pain.
Initial workup was done in some private hospital which
raised the suspicion of aortic dissection which was confirmed
on Transoesophageal echocardiography (TEE). 
Aortic dissection (DeBakey class I) was secondary to
some connective tissue disorder most probably due to
questionable Marfan syndrome and her primary pathology
was compounded by the haemodynamic stresses of the third
trimester of pregnancy.
When the patient arrived in the ER, her heart rate was
87 b/minute, B.P 90/60mmHg, R/R 20/minute and Spo2
100%.On examination, heart sounds showed diastolic mumur
at the aortic area. Regarding respiratory system, air entry was
equal bilaterally. There was no disparity of pulses in the upper
and lower limbs. 
Control of the heart rate and peripheral vascular
resistance is very important to avoid the progression of the
aortic dissection.
After applying the standard ASA monitoring, a wide
bore I/V cannula was introduced in the right arm and arterial
line in the left arm. After optimal preoxygenation, a rapid
sequence induction and intubation was done with Etomidate,
fentanyl and rocronium. Invasive montoring lines including
CVP and Swan Ganz were put in the right IJV. Another
arterial line was put in the left femoral artery for assessing the
perfusion of the lower limb and for back up in case the radial
arterial line did not work due to extention of aortic dissection.
All measures to prevent preterm labour were taken
including administration of intravenous magnesium and
nitroglycerine infusion. Preoperatively progesterone was
given as a prophylaxis against preterm labour.
When the pericardial cavity was opened it showed
haemopericardium (Figure-1). Ascending aorta opening
showed true and false lumens. The patient was put on the
cardiopulmonary bypass. The temperature was dropped down
to 32ºC. During the CPB, the important considerations were
to keep the flows and perfusion pressures optimal .The
haemoglobin was kept around 8gm/dl and PH neutral. The
adequacy of cardiac output was monitored through systemic
venous oxygen saturation. The ascending aorta and the aotic
valve were replaced with aortic root with inbuilt mechanical
valve as shown in Figure-2.
In the immediate post cardiopulmonary bypass period
the patient was bleeding profusely from the anastamotic sites
irrespective of utilization of all conventional methods of
haemostasis including multiple units of whole blood, fresh
frozen plasma, platelets, calcium and cryoprecipitates. The
bleeding was so profuse that the patient became hypotensive
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Figure-1: Aortic dissection rupturing into the pericardium.
Figure-2: Aortic root graft with mechanical valve.
due to hypovolaemia. As a last resort 1.2mg of recombinant
factor VII (containing 60 KIU of Factor VII) was injected.
The bleeding stopped and consequently haemodynamics got
stable. The patient was shifted to cardiac Intensive care unit
(CICU) with an open chest where she was monitored till all
the parameters became stable. The chest was then closed and
she was successfully extubated. Immediately on arrival in the
CICU, the foetus was evaluated but unfortunately the foetus
was dead. The possible factors could be hypothermia,
nonpulsatile flow and retrograde perfusion through the
femoral atery which could result in placental hypoperfusion. 
Discussion
The association between pregnancy and aortic
dissection has been well described in previous reports in the
literature. Acute aortic dissection during pregnancy,
particularly during the third trimester, accounts for half the
cases in women under the age of 40 years.5 The presence of
a pre-existing aortopathy secondary to a connective tissue
disorder increases the risk for dissection.
Becker and colleagues6 found that pregnancy carries a
mortality of 1.5%, whereas foetal mortality is up to 16.2%.
This is mostly dependent on the maturity of the foetus, and
some reports suggest that cardiopulmonary bypass may cause
intrauterine foetal death. 
Bleeding is relatively common during the post-bypass
period and after cardiac surgery, especially in patients with re-
do surgery, prolonged bypass time, and recent anti-platelet agent
use. The incidence of the bleeding complications are more in
parturients due to gestational thrombocytopenia and dilutional
coagulopathy. It is a cause of a significant morbidity and
mortality, prolonged ICU and hospital stay and increased cost.
Studies suggest that the action of rVIIa is dependent
on sufficient levels of coagulation factors (>30%),
specifically fibrinogen (>50-75 mcg/dl), Factor V and Factor
X (> 5-10%) and sufficient platelet count (50x109/ml). If pH
is below 7.2, the proportion of patients responding to rVIIa
decreases. Hypothermia decreases its effect at core body
temperature below 33°C. Current recommendations,
however, consider the use of rVIIa in refractory haemorrhage
in cardiac surgery appropriate in cases in which significant
clotting factor replacement therapy has occurred. The
suggested dose is 41-90 mcg/kg. The dose may have to be
repeated in 2 to 4 hours if bleeding persists.
Although rFVIIa is expensive, it would appear to be
cost effective when compared with the combined cost of large
amounts of blood and blood products. Moreover, the risks of
transfusion e.g. incompatibility, and infection cannot be
ignored. The earlier use of rFVIIa may also help to conserve
the already diminishing blood pool and stores.
It is important to note that the use of recombinant
factor VIIa requires attention to replacement of deficient
coagulation factors, red cells, fibrinogen, and platelets in
addition to more general measures such as avoidance of
hypothermia, acidaemia, and ongoing surgical bleeding.7
Use of rFVIIa should be considered for any patient
with coagulopathic haemorrhage in which surgically-
accessible bleeding has been controlled. Prospective trials of
FVIIa in patients with traumatic coagulopathy are strongly
indicated, and should focus on appropriate patient selection
and the dose and timing of therapy.8
Conclusion
In summary, even though most published studies
reported reduction in blood loss either as witnessed by
surgeon, decreased chest tube drainage or decreased need for
further blood products, in the absence of large double-blinded,
placebo-controlled, randomized studies, the exact role of
rVIIa in cardiac surgery is hard to predict with certainty.
Current data suggest a potential benefit in refractory bleeding,
but further investigation is warranted in order to design
guidelines on the use of rVIIa in cardiac surgery and to
determine its safety profile especially in the pregnant patients.
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